- April 11, 2016
- Taiho Pharmaceutical Co., Ltd.
Tiovita series to go on sale outside Japan Tiovita 3000 to Be Released in Hong Kong "Supporting the hard workers of Hong Kong"
Taiho Pharmaceutical Co., Ltd. announced today that it will release the nutritive drink Tiovita 3000 in Hong Kong on April 21, 2016.
Tiovita 3000 is a newly developed product based on Tiovita Drink (designated quasi-drug), which was originally launched in 1964 in Japan. The new product features a localized taste with a fresh grape flavor and label designed to meet consumer preferences in Hong Kong. It contains several nutritious ingredients, such as taurine, which is known for helping to heal fatigue, and more *B vitamins than were in the original Tiovita Drink.
Tiovita 3000 is produced using the clean water of the Yoshii River in Okayama prefecture, Japan at Taiho Pharmaceutical’s Okayama plant, which is known for its environmental initiatives. Taiho Pharmaceutical will distribute Tiovita 3000 in Hong Kong through a local distributer, RS Lifestyle Limited., which specializes in marketing and distributing OTC and healthcare supplement products. Sales will begin first at convenience stores.
Tiovita 3000 is named “速健能 3000” in Chinese: 速 means fast, referring to how quick it is to get good nutrition by consuming the drink; 健 stands for how the drink supports a healthy life; and 能 indicates the energy benefits of the drink. Taiho Pharmaceutical will promote this modern, tasty, and made-in-Japan product for Hong Kong’s busy workers to regain themselves quickly as what they want to be every day.
Taiho Pharmaceutical is determined to keep contributing to healthy living by providing Tiovita series.
* B vitamins included：Vitamin B1, Vitamin B2, Vitamin B6
Features of Tiovita 3000
・ Three times the taurine and twice the B vitamins of Tiovita Drink
・ 100mL drink supplies nutrition quickly and easily.
・ Refreshing grape flavor
・ Premium label designed to appeal to both men and women.
Information in this news release was current as of the original release date.
Taiho Pharmaceutical's press releases may contain information about prescription drugs including products currently under development, however information contained in the press releases are not intended to constitute promotion, advertisement, or medical advice.